Skip to main content

Your search for “Targeted Drug Delivery” returned 76 results

An HIV Prevention Pill for Transgender Persons

April 26, 2016

The California HIV/AIDS Research Program (CHRP) of University of California has awarded grants totaling $9.4 million to three teams of investigators to provide and evaluate PrEP – the HIV prevention pill – among transgender persons at risk for HIV acquisition in California.

Nanosponges Could Intercept Coronavirus Infection

June 17, 2020

Nanoparticles cloaked in human lung cell membranes and human immune cell membranes can attract and neutralize the SARS-CoV-2 virus in cell culture, causing the virus to lose its ability to hijack host cells and reproduce.

Controlling Cholesterol in Microglia Alleviates Chronic Pain, Opioid-Free

May 10, 2021

Using a mouse model, researchers discover pivotal role of cholesterol in chronic pain often caused by chemotherapy, and propose novel therapy.

Liangfang Zhang Makes MIT Technology Review’s Annual Innovators Under 35 List

August 21, 2013

MIT Technology Review has named Liangfang Zhang, a professor of nanoengineering at the University of California, San Diego, among the top 35 young innovators of 2013. For over a decade, the global media company has recognized a list of exceptionally talented technologists whose work has great potential to transform the…

Breaking Through to the Brain

May 5, 2022

…engineering nanoparticles that could target the portion of the patient’s brain that was injured, delivering specific therapeutics to treat the injury and improve the patient’s long-term quality of life. “It’s really a dire state for these patients, and TBI is unfortunately quite prevalent,” said Kwon. “Patients with a traumatic brain…

Nanosponge Vaccine Fights MRSA Toxins

December 2, 2013

Nanosponges that soak up a dangerous pore-forming toxin produced by MRSA (methicillin-resistant Staphylococcus aureus) could serve as a safe and effective vaccine against this toxin. This “nanosponge vaccine” enabled the immune systems of mice to block the adverse effects of the alpha-haemolysin toxin from MRSA—both within the bloodstream and on…

Cancer Treatment of Tomorrow, Today

February 6, 2024

Moores Cancer Center continues to bring state-of-the-art cancer treatments from the bench to the bedside.

Five Ph.D. students named Siebel Scholars

September 27, 2016

Five engineering graduate students from the University of California, San Diego have been named 2017 Siebel Scholars. The Siebel Scholars program recognizes exceptional students at the world’s leading graduate schools of business, computer science, and bioengineering and provides them with a financial award for their final year of studies.

Three Entrepreneurial UC San Diego Faculty Members To Join National Academy of Inventors

December 8, 2022

UC San Diego’s ranks now include 18 fellows of the National Academy of Inventors. Three professors have been named 2022 NAI fellows, the highest professional distinction awarded to academic inventors.

Surfing for a Cure

July 26, 2019

The Luau and Legends of Surfing Invitational brings together over 500 surfers, doctors and cancer survivors at Scripps Pier to catch a few waves, enjoy food and drink and raise money for cancer research.

Category navigation with Social links